OCREVUS CONNECTS™: your direct connection to Genentech

The support you need in one place

  • Answers to product-specific questions from Medical Information Specialists
  • Patient Navigators to support patients, practices, and infusion sites for access, reimbursement, infusion coordination, and patient assistance options
  • Additional resources (including live programs)

Call (844) OCREVUS (1-844-627-3887)
Monday through Friday, 9 am to 8 pm EST

Download the Patient Navigation Roadmap

This guide provides an overview of the services offered by Genentech and more information about Patient Navigators. Patient Navigators provide support to patients, practices, and infusion sites for access, reimbursement, infusion coordination, and patient assistance options.

6-month dosing schedule

The first dose of OCREVUS is administered as two 300 mg IV infusions 2 weeks apart. Subsequent doses are administered as a single 600 mg infusion every 6 months.

Learn more about IRRs

Learn how to manage Infusion-related reactions (IRRs) in your OCREVUS patients.